Rabbit Polyclonal CBX7 antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 62 publications.
View Alternative Names
Chromobox protein homolog 7, CBX7
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-cbx7 antibody (AB21873)
IHC image of cbx7 staining in Human normal prostate formalin fixed paraffin embedded tissue section, performed on a Leica BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab21873, 1μg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
- WB
Lab
Western blot - Anti-cbx7 antibody (AB21873)
All lanes:
Western blot - Anti-cbx7 antibody (ab21873) at 1 µg
Lane 1:
HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 10 µg
Lane 2:
Jurkat nuclear extract lysate (<a href='/en-us/products/unavailable/jurkat-nuclear-extract-lysate-ab14844'>ab14844</a>) at 10 µg
Lane 3:
Western blot - Hep G2 nuclear extract lysate (<a href='/en-us/products/cell-lysates/hep-g2-nuclear-extract-lysate-ab14660'>ab14660</a>) at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 28 kDa
Observed band size: 100 kDa,34 kDa,70 kDa
true
Exposure time: 30s
- WB
Project
Western blot - Anti-cbx7 antibody (AB21873)
All lanes:
Western blot - Anti-cbx7 antibody (ab21873) at 1 µg/mL
Lane 1:
HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2:
HeLa (Human epithelial carcinoma cell line) Nuclear Lysate at 10 µg
Lane 3:
Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 4:
Jurkat nuclear extract lysate (<a href='/en-us/products/unavailable/jurkat-nuclear-extract-lysate-ab14844'>ab14844</a>) at 10 µg
Lane 5:
HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 6:
Western blot - Hep G2 nuclear extract lysate (<a href='/en-us/products/cell-lysates/hep-g2-nuclear-extract-lysate-ab14660'>ab14660</a>) at 10 µg
Secondary
All lanes:
Goat Polyclonal to rabbit IgG - H&L - Pre adsorbed (HRP) at 1/3000 dilution
Predicted band size: 28 kDa
Observed band size: 100 kDa,34 kDa,70 kDa
false
- WB
CiteAb
Western blot - Anti-cbx7 antibody (AB21873)
Western Blotting using Anti-cbx7 antibody, ab21873. Publication image from Hu, S. et al., 2020, Genome Biol, 32093739. Legend direct from paper.
Non-classical function of CBX7 for the maintenance of pluripotency. a Heatmap showing CBX7, CBX7’s classical substrates H3K27me3 and H3K9me3, predicted cofactor NANOG, and H3K27ac enrichment around CBX7 ChIP-seq peak centers. Rows represent CBX7 binding sites and are ranked by normalized H3K27me3 signals. The colors indicate the normalized ChIP-seq enrichment level and the values are scaled by row. CBX7, NANOG, H3K27me3, H3K9me3, and H3K27ac ChIP-seq data were obtained from GSE64008, GSE90893, GSE58023, GSE90895, and GSE67867. b Stacked bar plot showing the percentages of classical sites, non-classical sites, and the whole genome that reside in promoter, gene body, and intergenic regions. The promoter is defined as ± 3 kb around TSS of the gene. c Real-time qPCR analysis for the expression of CBX7 and NANOG in wild type, Cbx7-knockout, and Cbx7-knockdown mESCs. Error bars represent the standard deviation for triplicate experiments, and unpaired t test with Welch’s correction was used to calculate the statistical significance for comparison (*p value < 0.05, **p value < 0.01, ***p value < 0.001, and n.s represents non-significant). d Western blot analysis of CBX7 and NANOG level in wild type, Cbx7-knockout, and Cbx7-knockdown mESCs. Tubulin was used as a loading control. Blots were cut before antibody application. Gel images for Western blot are shown in Additional file 1 : Fig. S6a. e The UCSC genome browser view of CBX7, H3K27me3, H3K9me3, NANOG, and H3K27ac enrichment at a previously reported enhancer of Nanog [37]. Enhancer loci are shaded in purple and signals represent ChIP-seq RPM. f Immunofluorescence staining for NANOG (red), OCT4 (green), DAPI (blue), and merged images in wild type, Cbx7-knockout, and Cbx7-knockdown mESCs. g The fluorescence intensity of NANOG for about 300 nuclei in wild type, Cbx7-knockout, and Cbx7-knockdown mESCs. Unpaired t test with Welch’s correction was used to calculate statistical significance for comparison
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CBX7 protein participates in the complex known as Polycomb Repressive Complex 1 (PRC1). This complex plays a significant role in the maintenance of cellular identity by regulating gene expression profiles important for stem cell pluripotency and differentiation. CBX7 binds to modified histones leading to chromatin compaction and gene silencing instrumental for preserving cell lineage integrity during development and cellular transformation.
Pathways
CBX7 interacts with several components in the cell cycle regulation and epigenetic modification pathways. Within the cell cycle regulation pathway it closely interacts with other Polycomb group proteins to control gene expression that governs cell proliferation and differentiation. In the context of epigenetic pathways CBX7 influences chromatin remodeling by interacting with proteins like BMI1 and RING1 thereby exerting control over the transcriptional landscape required for developmental and adaptive responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (62)
Recent publications for all applications. Explore the full list and refine your search
Molecular cell 85:3057-3073.e10 PubMed40803325
2025
Applications
Unspecified application
Species
Unspecified reactive species
STAR protocols 6:103597 PubMed39879359
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental hematology 142:104691 PubMed39613290
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer & metabolism 12:30 PubMed39456039
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:11008 PubMed38744845
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 27:109548 PubMed38600974
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of ovarian research 16:233 PubMed38037081
2023
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 27:14 PubMed38028179
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of molecular cell biology 15: PubMed37791390
2023
Applications
Unspecified application
Species
Unspecified reactive species
Circulation 147:1823-1842 PubMed37158107
2023
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com